AVAH — Aveanna Healthcare Holdings Income Statement
0.000.00%
Last trade - 00:00- $1.39bn
- $2.67bn
- $2.43bn
Annual income statement for Aveanna Healthcare Holdings, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,788 | 1,679 | 1,895 | 2,025 | 2,433 |
| Cost of Revenue | |||||
| Gross Profit | 553 | 542 | 595 | 636 | 810 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,430 | 1,728 | 1,887 | 1,885 | 2,183 |
| Operating Profit | -642 | -49.8 | 8.07 | 140 | 251 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -664 | -114 | -139 | 5.07 | 107 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -662 | -117 | -135 | -10.9 | 225 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -662 | -117 | -135 | -10.9 | 225 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -662 | -117 | -135 | -10.9 | 225 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.03 | 0.009 | -0.353 | -0.004 | 1.1 |